Tyrosine kinase inhibitors have become a revolutionary approach and drastically changed the landscape of treatment approaches in treating non small cell lung cancer. It enormously improved the quality of life in patients suffering from NSCLC. However, recent resistance development against various medications used has become a headache to address.